Canada markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
324.21-7.67 (-2.31%)
At close: 4:00PM EDT
322.80 -1.41 (-0.43%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close331.88
Open341.01
Bid322.20 x 1100
Ask322.30 x 800
Day's Range318.50 - 341.55
52 Week Range65.49 - 497.49
Volume17,153,210
Avg. Volume19,468,982
Market Cap130.866B
Beta (5Y Monthly)1.49
PE Ratio (TTM)38.30
EPS (TTM)8.46
Earnings DateNov. 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est349.33
  • Motley Fool

    2 Biotech Stocks Poised for Jaw-Dropping Growth

    Over the past 10 years, U.S. stocks have delivered outstanding returns for investors. The major stock indices such as the Dow Jones Industrial Average, the NASDAQ Composite, and the S&P 500 have all climbed by more than 200% during this boom period. For example, biotech innovators Axsome Therapeutics (NASDAQ: AXSM) and Moderna (NASDAQ: MRNA), along with electric-car giant Tesla (NASDAQ: TSLA), have all generated well over 1,000% returns on capital for investors in just the past three years.

  • Motley Fool

    Could Moderna Justify Its $129 Billion Valuation?

    The company's COVID-19 vaccine has been a massive success, but how much is the underlying technology worth?

  • Yahoo Finance

    NIH director on why Moderna's COVID-19 vaccine for teens is on hold

    Authorization for Moderna's (MRNA) COVID-19 vaccine for ages 12-17 was put on hold Friday in light of concerns over a rare side effect known as myocarditis, or a heart inflammation.